Finpecia 150片(15片x10) / 150天 Finasteride 最受歡迎、最有效的生髮口服藥

**送貨須知，凡貨件中含有口服產品，口服現時不能經順豐快遞派送，可提供住宅地址或辦公室地址派送**

【產品規格】 大盒包裝，每盒150片（15板×10片）。每片含量為1MG Finasteride。

【服用方法】 口服：1mg/次，1次/天，3個月為一療程。【有效日期】2026/02

【產品使用對像】限男仕使用

【產品簡介】
－1MG Finasteride，柔沛 Propecia 和波期卡 Proscar 最完美替代產品，享受較低價格的同時再也不用為了切分而煩惱了。
由印度廠家Cipla生產，因為印度國家的法律衡量產品專利標準是製作方法而非產品成分，所以印度可以生產很多歐美國家的專利產品，除了針對男性脂溢型脫 髮的專利產品Finpecia外，像「威而剛」等很多西方國家的專利產品，都可以在印度買到相同配方的低廉替代品。
大家聽到印度的廠家可能會有些懷疑，這就像老外看到中國的產品就會懷疑質量是否過關一樣，是偏見和不瞭解造成的。大 家可以在Google上搜索下 Finpecia或Cipla，Finpecia由於使用方便，價格較低廉，在歐美、日本等地有眾多發友使用，也有良好的反饋。Cipla是著名的印度上 市企業，也是歐洲認可的非本土最大的產品供應商，同時與美國的大型治藥企業也有著長期的合作。

【成功案例】
這是一個英國朋友的成功案例，轉載自外國的脫髮論壇。他名叫Oliver，持續服用Finpecia及使用Rogaine泡沫生髮水一年後，頭髮的恢復得到很好的效果。以下是他的自述：
發表於　2007年2月10日
中文翻譯：
我想跟大家分享我的治療成果。
我由去年十月份開始，每天服用Finpecia及Rogaine泡沫生髮水（生髮水每日使用兩次），到現在已經有4 至5個月了。我開始的時候是使用Kirkland的生髮水，但我感覺使用它後，頭會比較油，後來就轉用Rogaine泡沫生髮水，我已用了大概6個星期 了，覺得非常好用。（注：從上文下理推斷，Oliver在治療的4~5個月中，開始時是一直使用Kirkland生髮水，在後來的6個星期才開始轉用 Rogaine泡沫生髮水的）
以下是我在治療前的照片

治療4~5個月後的照片 (拍於2007年2月10日)
發表於 2007年10月23日

中文翻譯：
我現在仍然每天服用Finpecia及Rogaine泡沫生髮水（生髮水每日使用兩次）。
下面是治療一年後的照片，即使我的頭髮不能全部重新恢復，但我對於目前的止脫及頭髮生長情況，已經感到非常高興。

原文轉載自：http://stophairlossnow.ipbhost.com/index.php?showtopic=2011
【英文原廠說明書】

Finpecia

Finasteride Tablets USP

COMPOSITION

FINPECIATablets

Each film-coated tablet contains:

Finasteride USP ............... 1 mg

Colours: Titanium Dioxide and Quinoline Yellow WS

DOSAGE FORM

Film-coated Tablet

PHARMACOLOGY

Pharmacodynamics

Finasteride, a synthetic 4- azasteroid compound, is a specific inhibitor of 5 alpha- reductase, an intracellular enzyme that converts androgenic testosterone into 5alpha-dihydrotestosterone (DHT). Administration of finasteride 1 mg decreases scalp and serum DHT concentration, increased amounts of which are thought to be responsible for male pattern hair loss (androgenetic alopecia).

Pharmacokinetics

Absorption

In a study in 15 healthy young male subjects, the mean bioavailability of finasteride

1 mg tablets was 65% (range: 26–170%), based on the ratio of area under the curve (AUC) relative to an intravenous reference dose. At steady state following dosing with 1 mg/day (n=12), maximum finasteride plasma concentration averaged 9.2 ng/mL (range: 4.9–13.7 ng/mL) and was reached 1 to 2 hours post-dose. Bioavailability of finasteride was not affected by food.

Distribution

Mean steady-state volume of distribution was 76 litres (range: 44–96 litres; n=15). Approximately 90% of circulating finasteride is bound to plasma proteins. There is a slow accumulation phase for finasteride after multiple dosing.

Finasteride has been found to cross the blood-brain barrier.

Semen levels have been measured in 35 men taking finasteride 1 mg/day for 6 weeks and in 60% (21 of 35) of the samples, finasteride levels were undetectable (<0.2 ng/mL). The mean finasteride level was 0.26 ng/mL and the highest level measured was 1.52 ng/mL. Using the highest semen level measured and assuming 100% absorption from a 5 mL ejaculate per day, human exposure through vaginal absorption would be up to 7.6 ng per day, which is 750 times lower than the exposure from the no-effect dose for developmental abnormalities in Rhesus monkeys and 650-fold less than the dose of finasteride (5 μg), which had no effect on circulating DHT levels in men.

Metabolism

Finasteride is extensively metabolized in the liver, primarily via the cytochrome P450 3A4 enzyme subfamily. Two metabolites, the t-butyl side chain monohydroxylated and monocarboxylic acid metabolites, have been identified that possess no more than 20% of the 5alpha-reductase inhibitory activity of finasteride.

Excretion

Following an oral dose of 14 C-finasteride in men (n=6), a mean of 39% (range: 32–46%) of the dose was excreted in the urine in the form of metabolites; 57% (range: 51–64%) was excreted in the faeces.

Mean terminal half-life is approximately 5 to 6 hours in men, 18 to 60 years of age, and 8 hours in men more than 70 years of age.

INDICATIONS

FINPECIAis indicated for the treatment of male pattern hair loss (androgenetic alopecia) inMEN ONLY. Safety and efficacy have been demonstrated in men between the ages of 18 to 41 years with mild to moderate hair loss of the vertex and anterior mid-scalp area.FINPECIAis not indicated in women and children.

DOSAGE AND ADMINISTRATION

The recommended dosage is 1 mg once a day, with or without meals. In general, daily use for 3 months or more is necessary before benefit is observed. Continued use is recommended to sustain benefits. Withdrawal of treatment leads to a reversal of effect within 12 months.

CONTRAINDICATIONS

Hypersensitivity to any ingredient in the formulation.FINPECIAuse is contraindicated in women when they are or may potentially be pregnant.

WARNINGS AND PRECAUTIONS

Drug Interaction

No drug interactions of clinical importance have been identified. Finasteride does not appear to affect the cytochrome P450-linked drug metabolizing enzyme system. Compounds that have been tested in men include antipyrine, digoxin, propranolol, theophylline, and warfarin and no interactions were found.

Renal Impairment

No dosage adjustments are required.

Hepatic Impairment

To be used with caution since finasteride is metabolized extensively in the liver.

Pregnancy

Pregnancy Category X

Women should not handle crushed or brokenFINPECIAtablets when they are pregnant or may potentially be pregnant because of the possibility of absorption of finasteride and the subsequent potential risk to a male foetus.

Lactation

It is not known whether finasteride is excreted in human milk.

Paediatric Use

FINPECIA is not indicated for use in paediatric patients.

UNDESIRABLE EFFECTS

FINPECIAis generally well tolerated and side effects have usually been mild and transient. These include decreased libido, erectile dysfunction, and ejaculation disorders (primarily, decreased volume of ejaculate), breast tenderness and enlargement, hypersensitivity reactions, including rash, pruritus, urticaria, and swelling of the lips and face, and testicular pain.

OVERDOSAGE

In clinical studies, single doses of finasteride up to 400 mg and multiple doses of finasteride up to 80 mg/day for 3 months did not result in adverse reactions. Until further experience is obtained, no specific treatment for an overdose with finasteride can be recommended.

Significant lethality was observed in male and female mice at single oral doses of

1,500 mg/m2(500 mg/kg) and in female and male rats at single oral doses of

2,360 mg/m2(400 mg/kg) and 5,900 mg/m 2 (1,000 mg/kg), respectively.

SHELF-LIFE

3 years

STORAGE AND HANDLING INSTRUCTIONS

Store in a dry place at room temperature.

PACKAGING INFORMATION

FINPECIA Tablets Blister pack of 10 tablets

【延伸閱讀】

A: Both Propecia and Finpecia contain the active ingredient Finasteride 1mg. Finpecia is manufactured in India by the company Cipla. It comes in packets of 10. Finpecia contains the same chemical ingredient as Propecia, i.e. 1mg of Finasteride, but it is manufactured differently. In addition, it is less expensive.

Indian patent law allows companies in India to make medications that are patented by drug companies in other countries, since Indian law protects only the processes by which drugs are made and not medication itself. Therefore, if an Indian company finds another way to make a drug, it can legally do so.